Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check13 days agoChange DetectedRevision tag on the page changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedA banner about government funding status and NIH operations was added, with links to cc.nih.gov and opm.gov. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data). Introduced a new Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference0.1%

- Check70 days agoChange DetectedOnly a minor site revision update is visible, with Revision: v3.3.4 added and Revision: v3.3.3 removed; this change does not affect the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.